E. Frascella

529 total citations
18 papers, 392 citations indexed

About

E. Frascella is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, E. Frascella has authored 18 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in E. Frascella's work include Sarcoma Diagnosis and Treatment (7 papers), Renal and related cancers (3 papers) and Neuroblastoma Research and Treatments (3 papers). E. Frascella is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Renal and related cancers (3 papers) and Neuroblastoma Research and Treatments (3 papers). E. Frascella collaborates with scholars based in Italy, France and Netherlands. E. Frascella's co-authors include Angelo Rosolen, Modesto Carli, A Rosolen, Luisa Toffolatti, CR Pinkerton, Vito Ninfo, Lucia Masiero, Raffaella Colombatti, Michaël C.G. Stevens and Odile Oberlin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

E. Frascella

18 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Frascella Italy 13 196 176 124 87 55 18 392
Marc Ladanyi United States 6 224 1.1× 110 0.6× 120 1.0× 127 1.5× 83 1.5× 8 419
Ross Barner United States 12 94 0.5× 156 0.9× 143 1.2× 73 0.8× 112 2.0× 14 554
JR Downing United States 9 133 0.7× 331 1.9× 83 0.7× 82 0.9× 17 0.3× 9 823
Gilles Palenzuela France 6 270 1.4× 197 1.1× 109 0.9× 118 1.4× 64 1.2× 9 518
Małgorzata Babińska Poland 12 233 1.2× 133 0.8× 94 0.8× 77 0.9× 41 0.7× 20 394
Harry Fisher United States 8 164 0.8× 136 0.8× 89 0.7× 28 0.3× 155 2.8× 11 442
I‐Ting Yu Taiwan 12 82 0.4× 91 0.5× 113 0.9× 95 1.1× 88 1.6× 23 352
P.Y. Dietrich Switzerland 12 150 0.8× 83 0.5× 185 1.5× 108 1.2× 53 1.0× 17 452
J.-O. Bay France 10 82 0.4× 78 0.4× 138 1.1× 44 0.5× 39 0.7× 24 370
H M Golomb United States 13 88 0.4× 107 0.6× 139 1.1× 106 1.2× 25 0.5× 22 516

Countries citing papers authored by E. Frascella

Since Specialization
Citations

This map shows the geographic impact of E. Frascella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Frascella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Frascella more than expected).

Fields of papers citing papers by E. Frascella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Frascella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Frascella. The network helps show where E. Frascella may publish in the future.

Co-authorship network of co-authors of E. Frascella

This figure shows the co-authorship network connecting the top 25 collaborators of E. Frascella. A scholar is included among the top collaborators of E. Frascella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Frascella. E. Frascella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Frascella, E., et al.. (2011). Hyperbaric oxygen treatment of superficial soft tissue lesions in children with oncologic disease. SHILAP Revista de lepidopterología. 4(1). 1–1. 1 indexed citations
2.
Cutrona, Giovanna, Mariella Dono, Silvio Roncella, et al.. (2002). CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL. British Journal of Cancer. 86(11). 1776–1785. 33 indexed citations
3.
Toffolatti, Luisa, E. Frascella, Vito Ninfo, et al.. (2002). MYCN expression in human rhabdomyosarcoma cell lines and tumour samples. The Journal of Pathology. 196(4). 450–458. 26 indexed citations
4.
Dalerba, Piero, E. Frascella, Beatrice Macino, et al.. (2001). MAGE, BAGE andGAGE gene expression in human rhabdomyosarcomas. International Journal of Cancer. 93(1). 85–90. 33 indexed citations
5.
Frascella, E., Elisabetta Lenzini, Beat W. Schäfer, et al.. (2000). Concomitant Amplif ication and Expression of PAX7-FKHR and MYCN in a Human Rhabdomyosarcoma Cell Line Carrying a Cryptic t(1;13)(p36;q14). Cancer Genetics and Cytogenetics. 121(2). 139–145. 19 indexed citations
6.
Carli, Modesto, et al.. (2000). All-trans retinoic acid and interferon-α in the treatment of a patient with resistant metastatic osteosarcoma. Cancer. 89(12). 2661–2666. 21 indexed citations
7.
Basso, Katia, E. Frascella, Luigi Zanesco, & Angelo Rosolen. (1999). Improved Long-Distance Polymerase Chain Reaction for the Detection of t(8;14)(q24;q32) in Burkitt's Lymphomas. American Journal Of Pathology. 155(5). 1479–1485. 28 indexed citations
8.
Carli, Modesto, Raffaella Colombatti, Odile Oberlin, et al.. (1999). High-Dose Melphalan With Autologous Stem-Cell Rescue in Metastatic Rhabdomyosarcoma. Journal of Clinical Oncology. 17(9). 2796–2796. 74 indexed citations
9.
Frascella, E., Luisa Toffolatti, & Angelo Rosolen. (1998). Normal and Rearranged PAX3 Expression in Human Rhabdomyosarcoma. Cancer Genetics and Cytogenetics. 102(2). 104–109. 29 indexed citations
10.
Rosolen, A, E. Frascella, Marcella Petrone, et al.. (1998). In vitro and in vivo antitumor effects of retrovirus-mediated herpes simplex thymidine kinase gene-transfer in human medulloblastoma. Gene Therapy. 5(1). 113–120. 21 indexed citations
11.
Rosolen, A, Gerardo Favaretto, Guido Masarotto, et al.. (1998). Effects of all-trans retinoic acid and interferon alpha in peripheral neuroectodermal tumor cell cultures and xenografts.. International Journal of Oncology. 13(5). 943–9. 4 indexed citations
12.
Frascella, E.. (1998). Normal and rearranged PAX 3 expression in human rhabdomyosarcoma. Medical Entomology and Zoology. 102. 104–109. 7 indexed citations
13.
Frascella, E. & A Rosolen. (1998). Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction.. PubMed. 152(2). 577–83. 24 indexed citations
14.
Carli, Modesto, E. Frascella, Jan de Kraker, et al.. (1997). Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6. Medical and Pediatric Oncology. 29(4). 239–244. 37 indexed citations
15.
Rosolen, Angelo, et al.. (1997). Expression of type I interferon receptor in solid tumors of childhood.. PubMed. 10(1). 55–61. 12 indexed citations
16.
Carli, Modesto, E. Frascella, Jan de Kraker, et al.. (1997). Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6. Medical and Pediatric Oncology. 29(4). 239–244. 1 indexed citations
17.
Frascella, E., Kathy Pritchard‐Jones, Shakeel Modak, et al.. (1996). Response of previously untreated metastatic rhabdomyosarcoma to combination chemotherapy with carboplatin, epirubicin and vincristine. European Journal of Cancer. 32(5). 821–825. 21 indexed citations
18.
Rosolen, A, et al.. (1995). EPISOME GENERATED C-MYC ANTISENSE RNA INHIBITS GROWTH AND TUMORIGENICITY OF A HUMAN NEUROENDOCRINE TUMOR-CELL LINE. International Journal of Oncology. 6(1). 175–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Ladanyi Breakdown of academic impact, for papers by Ross Barner Breakdown of academic impact, for papers by JR Downing Breakdown of academic impact, for papers by Gilles Palenzuela Breakdown of academic impact, for papers by Małgorzata Babińska Breakdown of academic impact, for papers by Harry Fisher Breakdown of academic impact, for papers by I‐Ting Yu Breakdown of academic impact, for papers by P.Y. Dietrich Breakdown of academic impact, for papers by J.-O. Bay Breakdown of academic impact, for papers by H M Golomb
Rankless by CCL
2026